Medicinal significance of coumarins: A review

International Journal of Pharmaceutical Research

Volumn 4, Issue 2, 2012, Pages 16-19

  Bairagi, Shriram H ^a   Salaskar, Pooja P ^a   Loke, Sonal D ^a   Surve, Nilam N ^a   Tandel, Darshana V ^a   Dusara, Mitesh D ^a  

^a Department of Pharmaceutical Chemistry   (India)

Author keywords

Anticoagulant activity; Coumarin; Warfarin

Indexed keywords

ACENOCOUMAROL; ACETAMIDE; ACETIC ACID ETHYL ESTER; ACETOACETIC ACID; ACETOACETIC ACID ETHYL ESTER; AMINOCOUMARIN DERIVATIVE; BETA OXOCARBOXYLIC ACID ESTER; COUMARIN; ESTER DERIVATIVE; MACROLIDE; METRONIDAZOLE; NOVOBIOCIN; PHENOL; PHENPROCOUMON; QUINOLONE DERIVATIVE; SALICYLALDEHYDE; SIMVASTATIN; UNCLASSIFIED DRUG; WARFARIN; XIMELAGATRAN;

ANTIPHOSPHOLIPID SYNDROME; BLOOD CLOTTING DISORDER; CATALYST; CORONARY ARTERY THROMBOSIS; DEEP VEIN THROMBOSIS; DRUG DETERMINATION; DRUG HALF LIFE; DRUG MECHANISM; DRUG METABOLISM; DRUG STRUCTURE; DRUG SYNTHESIS; DRUG WITHDRAWAL; GINKGO BILOBA; GINSENG; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HUMAN; HYPOTHYROIDISM; INTERNATIONAL NORMALIZED RATIO; KNOEVENAGEL CONDENSATION; LIVER TOXICITY; LUNG EMBOLISM; REVIEW; STRUCTURE ANALYSIS; THROMBOSIS;

EID: 84872692044     PISSN: None     EISSN: 09752366     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Bye A.; King H. K.;. The biosynthesis of 4-hydroxycoumarin and dicoumarol by Aspergillus fumigatus Fresenius. Biochemical Journal, 1970; 117: 237-245.
2. John R.; Casley-Smith.; Robert Gwyn Morgan.; and Neil B. Piller.; Treatment of Lymphedema of the Arms and Legs with 5,6-Benzo-[alpha]-pyrone. October 14, Number 1993; 329 (16): 1158-1163.
3. Schäfer F. P.; (Ed.), Dye Lasers, Springer-Verlag, Berlin 3rd Ed 1990.
4. Duarte F. J. and Hillman L. W. (Eds.), Dye Laser Principles, Academic, New York, 1990.
5. Duarte F. J., Tunable Laser Optics (Elsevier-Academic, New York, Appendix of Laser Dyes.; 2003
6. Von Pechmann and Duisberg, Ber. 1883; 16: 2127.
7. 2O as Catalyst, Transactions C: Chemistry and Chemical Engineering, 16, 1,12-16.
8. Von Pechmann and Kraft, Ber. 1901; 34: 421.
9. Peters and Simonis, Ber. 1908; 41: 831.
10. Fries and Volk, Ann., footnote 1 1911; 379: 94.
11. Ukhov S. V.; Kon'shin, M. E.; and Odegova T. F.; Synthesis and antimicrobial activity of 2-iminocoumarin-3-carboxylic acid amides Pharmaceutical Chemistry Journal July 2001; 35(7): 17-18.
12. Sanjay Kumar;, Anil Saini;, and Jagir S. Sandhu;, LiBr-Mediated, solvent free von Pechmann reaction: facile and efficient method for the synthesis of 2Hchromen-2-ones, Arkivoc 2007(xv), 18-23.
13. Hua Zuo A. C; Geo Jose, Zhu-bo Li, Bu-Hyun Moon, Dong-Soo Shin, And Manjunath Ghateb;, Microwave-assisted synthesisof fluorinated coumarinosulfonamides Arkivoc 2008(ii), 183-189.
14. Chang S.; Grubbs R. H.; J. Org. Chem. 1998; 63: 864.
15. Beena Tyagi;, Manish K. Mishra;, Raksh V. Jasra;, Synthesis of 7-substituted 4-methyl coumarins by Pechmann reaction using nano-crystalline sulfatedzirconia Journal of Molecular Catalysis A: Chemical, 2007; 276: 47-56.
16. Alessandra da Silva Eustáquio.; Biosynthesis of aminocoumarin antibiotics in Streptomyces: Generation of structural analogues by genetic engineering and insights into the regulation of antibiotic production. DISSERTATION, 2004.
17. Maxwell, A;, The interaction between coumarin drugs and DNA gyrase. Mol Microbiol, 1993; 9: 681-686.
18. Maxwell A. DNA gyrase as a drug target. Biochem Soc Trans, 27, 48-53.
19. Lewis, R. J., Tsai, F. T. F., and Wigley D. B. Molecular mechanisms of drug inhibition of DNA gyrase. Bioessays, 1996; 18: 661-671.
20. Maxwell A.; and Lawson D. M.; The ATP-binding site of type II topoisomerases as a target for antibacterial drugs. Curr Top Med Chem,2003; 3: 283-303.
21. Ansell J.; Hirsh J.; Poller L.; Bussey H.; Jacobson A.; Hylek E. "The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy". Chest 126 (3 Suppl): 2004; 204S-233S.
22. Freedman M.D.; "Oral anticoagulants: pharmacodynamics, clinical indications and adverse effects". J Clin Pharmacol March 1992; 32 (3): 196-209.
23. Hirsh J.; Fuster V.; Ansell J.; Halperin JL.; "American Heart Association/American College of Cardiology Foundation guide to warfarin therapy". J. Am. Coll. Cardiol. 2003; 41 (9): 1633-52.
24. Baglin TP, Keeling DM, Watson HG "Guidelines on oral anticoagulation (warfarin): third edition-2005 update". Br. J. Haematol. February 2006; 132 (3), 277-85.
25. Hirsh J.; O'Donnell M.; Eikelboom JW.; "Beyond unfractionated heparin and warfarin: current and future advances". Circulation July 2007; 116 (5): 552-60.
26. Holbrook AM.; Pereira JA.; Labiris R.; et al. "Systematic overview of warfarin and its drug and food interactions". Arch. Intern. Med. 2005; 165 (10): 1095-1106.
27. Gage BF.; Fihn SD.; White RH.; "Management and dosing of warfarin therapy". Am. J. Med. October 2000; 109 (6): 481-8.
28. Juurlink DN.; "Drug interactions with warfarin: what clinicians need to know". CMAJ August 2007; 177 (4): 369-71.
29. Kurnik D.; Loebstein R.; Farfel Z.; Ezra D.; Halkin H.; Olchovsky D. "Complex drug-drug-disease interactions between amiodarone, warfarin, and the thyroid gland". Medicine (Baltimore) March 2004; 83 (2): 107-13.
30. Stephens MA, Self TH, Lancaster D, Nash T. "Hypothyroidism: effect on warfarin anticoagulation". South Med J December 1989; 82 (12): 1585-6.
31. Chute JP.; Ryan CP.; Sladek G.; Shakir KM "Exacerbation of warfarin-induced anticoagulation by hyperthyroidism". Endocr Pract 1997; 3 (2):77-9.
32. Kellett HA.; Sawers JS.; Boulton FE.; Cholerton S.; Park BK.; Toft AD "Problems of anticoagulation with warfarin in hyperthyroidism". Q J Med January 1986; 58 (225): 43-51.
33. Weathermon R.; Crabb DW "Alcohol and medication interactions". Alcohol Res Health 1999; 23 (1): 40-54.
34. Austin.; Steve and Batz.; Forrest Lininger.; Schuyler W. ed. A-Z guide to drug-herb-vitamin interactions: how to improve your health and avoid problems when using common medications and natural supplements together. Roseville, Calif: Prima Health. ISBN 0-7615-1599-2, 1999; p. 224.
35. "Information Pharmacists' news" (PDF). Information Centre Bulletin. 1 Lambeth High Street, London SE1 7JN: Royal Pharmaceutical Society of Great Britain. February 2008. p. 1. Retrieved 14 January 2009.
36. Dr Jo Barnes BPharm MRPharmS; Working Group on Complementary Medicine (September 2002). "Herbmedicine interactions: St John's Wort (Hypericum perforatum) Useful information for pharmacist" (PDF). 1 Lambeth High Street, London SE1 7JN: Royal Pharmaceutical Society of Great Britain, Retrieved 14 January 2009; 5.